Autologous peripheral-blood progenitor-cell support following high-dose chemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1306-1313

  Marit, G ^a   Faberes, C ^a   Pico, J L ^a   Boiron, J M ^a   Bourhis, J H ^a   Brault, P ^a   Bernard, P ^a   Foures, C ^a   Cony Makhoul, P ^a   Puntous, M ^a   Vezon, G ^a   Broustet, A ^a   Girault, D ^a   Reiffers, J ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 9244255776     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1306     Document Type: Article

References (36)

1. Durie BGM, Dixon DO, Carter S, et al: Improved survival duration with combination chemotherapy induction for multiple myeloma: A Southwest Oncology Group study. J Clin Oncol 8:1227-1237, 1986
2. Barlogie B, Smith L, Alexanian R: Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 310:1353-1356, 1984
3. Mac Elwain TJ, Powles RL: High-dose intravenous melphalan for plasma cell leukemia and myeloma. Lancet 2:822-824, 1983
4. Lenhard RE, Oken MM, Barnes JM, et al: High-dose cyclophosphamide: An effective treatment for advanced multiple myeloma. Cancer 53:1456-1460, 1984
5. Barlogie B, Hall R, Zander A, et al: High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 67:1298-1301, 1986
6. Barlogie B, Alexanian R, Dicke KA, et al: High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 70:869-872, 1987
7. Gahrton G, Tura S, Ljungman P, et al: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325:1267-1273, 1991
8. Mariette X, Fermand JP, Brouet JC: Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant 14:47-50, 1994
9. Reiffers J, Marit G, Vezon G, et al: Autologous blood stem cell grafting in hematological malignancies. Present status and future directions. Transfus Sci 13:399-405, 1992
10. Mark G, Pico J, Boiron JM, et al: The use of peripheral blood stem cell transplantation in multiple myeloma: A report of 26 cases, in Zander AR, Barlogie B (eds): Autologous Bone Marrow Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Multiple Myeloma. Berlin, Germany, Springer-Verlag, 1993, pp 170-172
11. Durie BGM, Salmon SE: Multiple myeloma macroglobulinemia and monoclonal gammopathies, in Hoffbrand AV, Brain MC, Hirsh J (eds): Recent Advances in Haematology. New York, NY, Churchill-Livingstone, 1977, pp 243-261
12. Durie BGM, Salmon SE: A clinical staging system for multiple myeloma. Cancer 36:842-854, 1975
13. Boiron JM, Marit G, Faberes C, et al: Collection of peripheral blood stem cells in multiple myeloma following single dose high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony stimulating factor. Bone Marrow Transplant 12:49-55, 1993
14. Reiffers J, Leverger G, Marit G, et al: Haematopoietic reconstitution after autologous blood stem cell transplantation, in Gale RP, Champlin R (eds): Bone Marrow Transplantation: Current Controversies. New York, NY, Liss, 1989, pp 313-320
15. Bouzgarrou R, Cristol G, Hau F, et al: Cryopreservation of haematopoietic peripheral blood stem cells in Grambo freezing bags. Infusion of peripheral blood stem cells from the peripheral blood, in Areman E, Deeg HJ, Sacher RA (eds): Bone Marrow and Stem Cells Proceedings: A Manual of Current Techniques. Philadelphia, PA, Davis, 1992, pp 357-363
16. Gore ME, Viner C, Meldrum M, et al: Intensive treatment of multiple myeloma and criteria for complete remission. Lancet 2:879-881, 1989
17. Mandelli F, Avisati G, Amadori S, et al: Maintenance treatment with recombinant interferon alpha 2b in patients with multiple myeloma responding to conventional induction therapy. N Engl J Med 332:1430-1434, 1990
18. Barlogie B, Jagannath S: Autotransplants in myeloma. Bone Marrow Transplant 10:37-44, 1992 (suppl 1)
19. Barlogie B, Gahrton G: Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 7:71-79, 1991
20. To LB, Davy MLJ, Haylock DN, et al: Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide. Bone Marrow Transplant 4:595-596, 1989
21. Gianni AM, Siena S, Bregni M, et al: Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet 2:580-585, 1989
22. Attal M, Huguet F, Schlaifer D, et al: Intensive combined therapy for previously untreated aggressive myeloma. Blood 79:1130-1136, 1992
23. Fermand JP, Levy Y, Gerota J, et al: Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cell autologous graft. Blood 82:2005-2009, 1993
24. Jagannath S, Barlogie B, Dicke K, et al: Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 76:1860-1866, 1990
25. Harousseau JL, Milpied N, Laporte JP, et al: Double-intensive therapy in high-risk multiple myeloma. Blood 79:2827-2833, 1992
26. Harousseau JL, Attal M, Divine M, et al: Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. Bone Marrow Transplant 15:963-969, 1995
27. Anderson KC, Barut A, Ritz J, et al: Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 77:712-720, 1993
28. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390-397, 1995
29. Billadcau D, Quam L, Thomas W, et al: Detection and quantification of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818-1824, 1992
30. Ventura GJ, Barlogie B, Hester JP, et al: High-dose cyclophosphamide BCNU and VP-16 with autologous blood stem cell support for refractory multiple myeloma. Bone Marrow Transplant 5:265-268, 1990
31. Tricot G, Jagannath S, Vesole D, et al: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588-596, 1995
32. Barlogie B, Jagannath S, Dixon DO, et al: High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma. Blood 76:677-680, 1990
33. Jagannath S, Vesole DH, Glenn L, et al: Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 80:1666-1672, 1992
34. Harousseau JL, Attal M, Divine M, et al: Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French Registry on Autologous Transplantation in Multiple Myeloma. Blood 85:3077-3085, 1995
35. Attal M, Harousseau JL, Stoppa AM, et al: High-dose therapy in multiple myeloma: A prospective randomized study of the Intergroupe Français du Myélome. Blood 84:198a, 1994 (suppl 1, abstr 1530)
36. Tricot G, Jagannath S, Vesole DH, et al: Relapse of multiple myeloma after autologous transplantation: Survival after salvage therapy. Bone Marrow Transplant 16:7-11, 1995